Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 3/20 | 0.55 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.55 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.47 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.47 |
| ▸ | SELE | P16581 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.44 |
| ▸ | GJA1 | P17302 | 1/20 | 0.43 |
| ▸ | GJB2 | P29033 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | IGF2R | P11717 | 1/20 | 0.42 |
| ▸ | AMY2A | P04746 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15991626 | 1.00 | LGALS3 (0.55) | LGALS3LGALS8LGALS4GAAENGASE | |
| SCHEMBL13764350 | 1.00 | LGALS3 (0.55) | LGALS3LGALS8LGALS4GAAENGASE | |
| SCHEMBL13998385 | 1.00 | LGALS3 (0.55) | LGALS3LGALS8LGALS4GAAENGASE | |
| SCHEMBL18685528 | 1.00 | LGALS3 (0.55) | LGALS3LGALS8LGALS4GAAENGASE | |
| SCHEMBL13917316 | 1.00 | LGALS3 (0.55) | LGALS3LGALS8LGALS4GAAENGASE | |
| SCHEMBL18680144 | 1.00 | LGALS3 (0.55) | LGALS3LGALS8LGALS4GAAENGASE | |
| SCHEMBL14417713 | 1.00 | LGALS3 (0.55) | LGALS3LGALS8LGALS4GAAENGASE | |
| SCHEMBL7695698 | 0.89 | GAA (0.56) | LGALS3LGALS8LGALS4GAACA2 | |
| SCHEMBL15991620 | 0.89 | LGALS8 (0.46) | LGALS3LGALS8LGALS4GAASELE | |
| SCHEMBL18685538 | 0.87 | LGALS3 (0.59) | LGALS3LGALS8LGALS4CD209SELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080112932-A1 | Methods and reagents for the enhancement of virus transduction in the bladder epithelium | CELL GENESYS, INC. | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080112932-A1 | Methods and reagents for the enhancement of virus transduction in the bladder epithelium | EGFR, MUC1, PLAUR | LGALS3 175/4885LGALS8 155/4885LGALS4 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.